| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $1.3B | $1.6B | $3.6B | $1.9B | $0.9B | $0.3B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $-0.2B | $0.2B | $2.3B | $0.9B | $0.2B | $0.1B | $0.1B |
| Net Income | $0.4B | $-0.2B | $0.2B | $1.1B | $-0.2B | $-0.1B | $0.1B | $0.1B |
| EPS (Basic) | $1.43 | $-0.76 | $0.76 | $4.75 | $-1.12 | $-0.39 | $0.22 | $0.61 |
| EPS (Diluted) | $1.43 | $-0.76 | $0.76 | $4.11 | $-1.12 | $-0.39 | $0.19 | $0.61 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.0B | $6.4B | $6.3B | $5.7B | $4.7B | $4.6B | $4.7B | $2.2B |
| Current Assets | $0.4B | $0.3B | $0.5B | $0.6B | $0.3B | $0.2B | $0.3B | $0.2B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $4.0B | $4.0B | $3.9B | $3.4B | $3.5B | $3.2B | $3.1B | $1.6B |
| Current Liabilities | $0.7B | $0.6B | $0.7B | $0.8B | $0.6B | $0.4B | $0.4B | $0.2B |
| Stockholders' Equity | $2.6B | $2.2B | $2.4B | $2.3B | $1.0B | $1.3B | $1.1B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.6B | $1.0B | $1.7B | $0.9B | $0.6B | $0.5B | $0.1B |
| Investing Cash Flow | $-0.9B | $-1.1B | $-1.4B | $-1.1B | $-0.6B | $-0.5B | $-1.2B | $-0.2B |
| Capital Expenditures | $1.3B | $1.1B | $1.4B | $1.1B | $0.7B | $0.5B | $0.5B | $0.2B |
| Financing Cash Flow | $0.0B | $0.5B | $0.4B | $-0.6B | $-0.3B | $-0.1B | $0.7B | $-0.8B |